Articles from BioResearch Compliance Report (July 1, 2006)

1-12 out of 12 article(s)

Title	Author	Type	Words
4-item 483 to contract lab for poor quality control, lack of test procedures.			672
Adaptive trials lead to enhanced patient safety, more efficient Phase I/II studies.	Pickett, Joseph		388
Baltimore IRB cited in 9-item 483 for failure to follow written procedures.			443
BiMo inspection FOIA log.			162
CI clears FDA audit.	Frost, Adaani	Brief article	240
CTS intuitive, easy to implement and can be done in short time, expert says.			392
FDA overviews progress in getting the public, health care community more involved in drug safety.	Flickinger, Bruce		618
Five new guidance documents eyed to aid development of 'adaptive clinical studies,' FDA's Gottlieb says.	Pickett, Joseph	Clinical report	836
IRB Determination letters.			201
NIDPOE letters.			1287
Points to consider in making GLP decisions include protocols, QA, SOPs.	Pickett, Joseph		690
Warning letters.			464